Lower risk seen for 90-day mortality and intensive care unit mortality. HealthDay News — Among adults in the intensive care unit with sepsis or septic shock, the use of prolonged β-lactam antibiotic ...
Please provide your email address to receive an email when new articles are posted on . When comparing continuous vs. intermittent infusions, the absolute difference in 90-day mortality was ...
At 90 days, 22% of patients receiving extended-infusion beta-lactam therapy had died compared with 28% of patients who received intermittent infusions (adjusted OR 0.71, 95% CI 0.52-0.97), reported ...
About The Study: The observed difference in 90-day mortality between continuous versus intermittent infusions of β-lactam antibiotics did not meet statistical significance in the primary analysis.
About The Study: Among adults in the intensive care unit who had sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions was associated with a reduced risk of 90-day mortality ...
DENVER & MAHWAH, N.J.--(BUSINESS WIRE)-- ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (KRMD) today jointly announced an agreement leveraging KORU Medical’s FreedomEDGE® infusion system as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback